Replies to post #518575 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

When a biotech is burying trial issues like NWBO, they bury it in the SEC 10K filings. NWBO did -- didn't inform the clinicians, the peer-reviewers, the investors, just buried it. It is VERY relevant as the FDA is certainly going to give it significant attention. But OTC retail investors don't read SEC filings. And clearly are in denial, rationalizing bad news.